NASH, NAFLD, what's that?

被引：0
|
作者：
Lecerf, Jean-Michel [1 ]
机构：
[1] Inst Pasteur, Ctr Prevent Sante Longevite, Serv Nutr & Act Phys, Lille, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2022年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：80 / 80
页数：1
相关论文
共 50 条
  • [1] Role of Exercise in NAFLD/NASH: What is the Right Prescription?
    Luis Calzadilla Bertot
    Leon Anton Adams
    Current Hepatology Reports, 2017, 16 (4) : 356 - 365
  • [2] NAFLD/NASH
    Bugianesi, Elisabetta
    Petta, Salvatore
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 549 - 550
  • [3] NAFLD/NASH and Diabetes
    Garg, Kavita
    Brackett, Scott
    Hirsch, Irl B.
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : S174 - S186
  • [4] NAFLD and NASH and Diabetes
    Garg, Kavita
    Reinicke, Trenton
    Garg, Satish K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : S198 - S205
  • [5] NASH/NAFLD management
    James, OFW
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2002, 65 (04) : 200 - 203
  • [6] Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
    Zafer, Maryam
    Dave, Shravan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (05) : 648 - 649
  • [7] Pathological Findings of NASH and NAFLD: for Guidebook of NASH and NAFLD, 2015: The Japan Society of Hepatology
    Effendi, Kathryn
    Harada, Kenichi
    Hashimoto, Etsuko
    Kage, Masayoshi
    Koike, Kazuhiko
    Kondo, Fukuo
    Nakano, Masayuki
    Ojima, Hidenori
    Okanoue, Takeshi
    Sakamoto, Michiie
    Sumida, Yoshio
    Tsujikawa, Hanako
    Yamada, Gotaro
    Zen, Yoh
    HEPATOLOGY RESEARCH, 2017, 47 (01) : 3 - 10
  • [8] NAFLD, NASH and liver cancer
    Gregory A. Michelotti
    Mariana V. Machado
    Anna Mae Diehl
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 656 - 665
  • [9] Salidroside in the Treatment of NAFLD/NASH
    Qu, Baozhen
    Liu, Xuemao
    Liang, Yanjiao
    Zheng, Keke
    Zhang, Chunling
    Lu, Linlin
    CHEMISTRY & BIODIVERSITY, 2022, 19 (12)
  • [10] An Overview of NAFLD/NASH in Japan
    Kim, Soo Ryang
    Kim, Ke Ih
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2016, 136 (04): : 565 - 572
12345